These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Long-term beta blockade: possible protection from myocardial infarction. Fox KM; Chopra MP; Portal RW; Aber CP Br Med J; 1975 Jan; 1(5950):117-9. PubMed ID: 234266 [TBL] [Abstract][Full Text] [Related]
63. Effect of propranolol on mortality in patients with angina. Lambert DM Postgrad Med J; 1976; 52 Suppl 4(603):57-60. PubMed ID: 9631 [TBL] [Abstract][Full Text] [Related]
64. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris. Coltart DJ; Hamer J Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080 [No Abstract] [Full Text] [Related]
66. The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations. Thomas M Acta Med Scand Suppl; 1976; 587():185-91. PubMed ID: 3097 [No Abstract] [Full Text] [Related]
67. Beta blockade and the effects of stress on the normal and ischaemic heart. Prichard BN Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S9-18. PubMed ID: 6118124 [TBL] [Abstract][Full Text] [Related]
68. Combined therapy with beta-adrenergic blockers and calcium-antagonists in patients with ischemic heart disease. Winniford MD; Hillis LD Herz; 1982 Aug; 7(4):243-9. PubMed ID: 6127300 [No Abstract] [Full Text] [Related]
69. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol. Wilson AG; Brooke OG; Lloyd HJ; Robinson BF Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958 [TBL] [Abstract][Full Text] [Related]
70. [Clinical and metabolic effects of metipranolol]. Cottini E; Barbanti P; Lunetta M; Dimaiuta G; Emma V; Sorrentino F Boll Soc Ital Cardiol; 1981; 26(10):1341-8. PubMed ID: 6129875 [No Abstract] [Full Text] [Related]
71. Editorial: Discontinuation of propranolol therapy. Cause of rebound angina pectoris and acute coronary events. Harrison DC; Alderman EL Chest; 1976 Jan; 69(1):1-2. PubMed ID: 1244260 [No Abstract] [Full Text] [Related]
74. [Coronary and left ventricular dynamics of three substances with different beta-blocking effects: Propranolol, Pindolol, and Practolol]. Moccetti T; Halter J; Lichtlen P Schweiz Med Wochenschr; 1972 Mar; 102(12):422-5. PubMed ID: 4401753 [No Abstract] [Full Text] [Related]
75. Beta blockers after myocardial infarction--aspects on study design based on current knowledge. Vedin A; Wilhelmsson C Acta Med Scand Suppl; 1981; 651():227-33. PubMed ID: 6119877 [TBL] [Abstract][Full Text] [Related]
76. Protection from morbidity and mortality from first infarcts: the case for beta-blockade. Lambert DM Aust Fam Physician; 1978 Jun; Suppl():5-10. PubMed ID: 708313 [TBL] [Abstract][Full Text] [Related]
77. [Choice of beta-blocking agents]. Iisalo E Duodecim; 1986; 102(22):1642-50. PubMed ID: 2879719 [No Abstract] [Full Text] [Related]
78. [Evaluation by echocardiography of the valve of beta-blockers in angina pectoris and in the acute phase of myocardial infarction]. Chapelle MJ Nouv Presse Med; 1978 Sep; 7(31):2753-8. PubMed ID: 30956 [No Abstract] [Full Text] [Related]
79. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris. Sandler G; Clayton GA Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983 [TBL] [Abstract][Full Text] [Related]
80. Comparative study of two beta-adrenergic blocking drugs in angina pectoris. Stroescu V; Theodorini S; Creţescu R Rev Roum Med Intern; 1974; 11(3):307-11. PubMed ID: 4152108 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]